vs
Side-by-side financial comparison of Clear Channel Outdoor Holdings, Inc. (CCO) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $461.5M, roughly 1.3× Clear Channel Outdoor Holdings, Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 1.7%, a 32.7% gap on every dollar of revenue. On growth, Clear Channel Outdoor Holdings, Inc. posted the faster year-over-year revenue change (8.2% vs 4.8%). Over the past eight quarters, Clear Channel Outdoor Holdings, Inc.'s revenue compounded faster (18.8% CAGR vs 4.6%).
Clear Channel Outdoor Holdings, Inc. is a multinational corporation focused on outdoor advertising. The company is based in San Antonio, Texas.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
CCO vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $461.5M | $622.0M |
| Net Profit | $8.0M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | 23.3% | 62.4% |
| Net Margin | 1.7% | 34.4% |
| Revenue YoY | 8.2% | 4.8% |
| Net Profit YoY | 144.8% | 2.9% |
| EPS (diluted) | $0.01 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $461.5M | $622.0M | ||
| Q3 25 | $405.6M | $609.3M | ||
| Q2 25 | $402.8M | $578.7M | ||
| Q1 25 | $334.2M | $568.2M | ||
| Q4 24 | $426.7M | $593.6M | ||
| Q3 24 | $375.2M | $564.7M | ||
| Q2 24 | $376.5M | $537.3M | ||
| Q1 24 | $326.8M | $568.0M |
| Q4 25 | $8.0M | $214.2M | ||
| Q3 25 | $-60.1M | $288.2M | ||
| Q2 25 | $9.5M | $30.2M | ||
| Q1 25 | $62.5M | $238.3M | ||
| Q4 24 | $-17.9M | $208.2M | ||
| Q3 24 | $-32.5M | $544.0M | ||
| Q2 24 | $-39.2M | $102.0M | ||
| Q1 24 | $-89.7M | $4.8M |
| Q4 25 | 23.3% | 62.4% | ||
| Q3 25 | 19.9% | 70.1% | ||
| Q2 25 | 19.2% | 36.3% | ||
| Q1 25 | 13.5% | 94.0% | ||
| Q4 24 | 23.5% | 60.9% | ||
| Q3 24 | 17.8% | — | ||
| Q2 24 | 18.2% | 50.2% | ||
| Q1 24 | 13.4% | -13.0% |
| Q4 25 | 1.7% | 34.4% | ||
| Q3 25 | -14.8% | 47.3% | ||
| Q2 25 | 2.4% | 5.2% | ||
| Q1 25 | 18.7% | 41.9% | ||
| Q4 24 | -4.2% | 35.1% | ||
| Q3 24 | -8.7% | 96.3% | ||
| Q2 24 | -10.4% | 19.0% | ||
| Q1 24 | -27.4% | 0.8% |
| Q4 25 | $0.01 | $0.49 | ||
| Q3 25 | $-0.12 | $0.67 | ||
| Q2 25 | $0.02 | $0.07 | ||
| Q1 25 | $0.13 | $0.55 | ||
| Q4 24 | $-0.03 | $0.46 | ||
| Q3 24 | $-0.07 | $1.21 | ||
| Q2 24 | $-0.08 | $0.23 | ||
| Q1 24 | $-0.19 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $190.0M | $618.7M |
| Total DebtLower is stronger | $5.1B | $9.0B |
| Stockholders' EquityBook value | $-3.4B | $9.7B |
| Total Assets | $3.8B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $190.0M | $618.7M | ||
| Q3 25 | $155.0M | $938.9M | ||
| Q2 25 | $138.6M | $631.9M | ||
| Q1 25 | $395.8M | $1.1B | ||
| Q4 24 | $109.7M | $929.0M | ||
| Q3 24 | $201.1M | $950.1M | ||
| Q2 24 | $189.3M | $1.8B | ||
| Q1 24 | $193.2M | $843.0M |
| Q4 25 | $5.1B | $9.0B | ||
| Q3 25 | $5.1B | $8.9B | ||
| Q2 25 | $5.1B | $8.0B | ||
| Q1 25 | $5.3B | $7.6B | ||
| Q4 24 | $5.7B | $7.6B | ||
| Q3 24 | $5.7B | $7.6B | ||
| Q2 24 | $5.7B | $7.6B | ||
| Q1 24 | $5.7B | $6.1B |
| Q4 25 | $-3.4B | $9.7B | ||
| Q3 25 | $-3.5B | $9.6B | ||
| Q2 25 | $-3.4B | $9.5B | ||
| Q1 25 | $-3.4B | $9.8B | ||
| Q4 24 | $-3.6B | $10.3B | ||
| Q3 24 | $-3.6B | $10.3B | ||
| Q2 24 | $-3.6B | $9.8B | ||
| Q1 24 | $-3.5B | $9.9B |
| Q4 25 | $3.8B | $19.6B | ||
| Q3 25 | $3.8B | $19.3B | ||
| Q2 25 | $3.8B | $18.3B | ||
| Q1 25 | $4.0B | $17.6B | ||
| Q4 24 | $4.8B | $18.2B | ||
| Q3 24 | $4.6B | $18.0B | ||
| Q2 24 | $4.5B | $17.7B | ||
| Q1 24 | $4.6B | $16.1B |
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $56.3M | $827.1M |
| Free Cash FlowOCF − Capex | $30.3M | — |
| FCF MarginFCF / Revenue | 6.6% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | 7.04× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $32.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.3M | $827.1M | ||
| Q3 25 | $56.2M | $702.6M | ||
| Q2 25 | $-12.6M | $364.0M | ||
| Q1 25 | $14.9M | $596.1M | ||
| Q4 24 | $29.3M | $742.5M | ||
| Q3 24 | $54.5M | $703.6M | ||
| Q2 24 | $30.8M | $658.2M | ||
| Q1 24 | $-34.8M | $664.6M |
| Q4 25 | $30.3M | — | ||
| Q3 25 | $41.4M | — | ||
| Q2 25 | $-29.2M | — | ||
| Q1 25 | $-10.6M | — | ||
| Q4 24 | $-27.8M | — | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $-61.0M | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | -7.2% | — | ||
| Q1 25 | -3.2% | — | ||
| Q4 24 | -6.5% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | -18.7% | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 7.6% | — | ||
| Q4 24 | 13.4% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | 8.0% | — |
| Q4 25 | 7.04× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | -1.32× | 12.06× | ||
| Q1 25 | 0.24× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCO
Segment breakdown not available.
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
